REVIEW article
Front. Physiol.
Sec. Vascular Physiology
Volume 16 - 2025 | doi: 10.3389/fphys.2025.1624225
Role of vascular endothelial dysfunction and metabolic eprogramming of immune cells in the development and ogression of atherosclerosis
Provisionally accepted
- 1Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China
- 2jiaxing, jiaxing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The pathogenesis of atherosclerosis (AS) involves a complex interaction between vascular endothelial dysfunction and immunometabolic disorders. During the process of AS, vascular endothelial cells(ECs) are affected by multiple environmental stimuli ( oxidative stress, shear force abnormalities) and undergo endothelial dysfunction, which is mainly manifested by a shift in energy metabolism toward aerobic glycolysis (the Warburg effect) and proliferation of ECs, which in turn leads to vascular remodeling and luminal narrowing. Meanwhile, infiltrating immune cellsundergo phenotypic polarization and functional alterations in response to stimulation of the AS microenvironment ( hypoxia,inflammatory factor enrichment) and adapt to the energy demand through metabolic reprogramming (enhanced glycolysis, imbalance of fatty acid oxidation,FAO) to maintain their activation, proliferation, and inflammatory effects. However, such adaptive metabolic changes may exacerbate lipid phagocytosis and inflammatory responses, further promoting AS progression. Currently, key controversies remain in the therapeutic strategy of AS: should the therapeutic target of AS be centered oncorrecting vascular endothelial dysfunction or targeting the modulation of immune cell metabolic reprogramming? In addition, the causal relationship between the two has not been fully elucidated -is it endothelial dysfunction that triggers immune metabolic disorders, or is it the aberrant activation of immune cells that exacerbates endothelial damage? How do the two synergize to drive the cascade response in AS? In this article, the dynamic interplay between vascular endothelial dysfunction and immune-metabolic reprogramming in the development of AS will be systematically described and analyzed from the perspectives of molecular mechanisms and therapeutic targets, and case studies will be presented.
Keywords: metabolic reprogramming, Glycolysis, Oxidative Phosphorylation, Macrophages, T lymphocytes, Endothelial cell dysfunction, Atherosclerosis
Received: 09 May 2025; Accepted: 26 Aug 2025.
Copyright: © 2025 Zhili, Zhimin and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guo Zhili, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.